Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal

Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal

Submitted by admin on July 11, 2023 - 11:27pm
Source: 
Medical Marketing and Media
News Tags: 
JNJ
Janssen
Nanobiotix
NBTXR3
soft tissue sarcoma
Hensify
Headline: 
Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal
snippet: 


Nanobiotix, which was quickly running out of funding, got a lifeline from Janssen in the form of a pact to co-develop and commercialize radio-enhancer NBTXR3.

Do Not Allow Advertisers to Use My Personal information